| Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial DJ Parekh, IM Reis, EP Castle, ML Gonzalgo, ME Woods, RS Svatek, ... The Lancet 391 (10139), 2525-2536, 2018 | 771 | 2018 |
| The economics of bladder cancer: costs and considerations of caring for this disease RS Svatek, BK Hollenbeck, S Holmäng, R Lee, SP Kim, A Stenzl, Y Lotan European urology 66 (2), 253-262, 2014 | 590 | 2014 |
| Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer DJ McConkey, W Choi, L Marquis, F Martin, MB Williams, J Shah, ... Cancer and Metastasis Reviews 28, 335-344, 2009 | 440 | 2009 |
| Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial SA Boorjian, M Alemozaffar, BR Konety, ND Shore, LG Gomella, ... The Lancet Oncology 22 (1), 107-117, 2021 | 381 | 2021 |
| Perioperative outcomes and oncologic efficacy from a pilot prospective randomized clinical trial of open versus robotic assisted radical cystectomy DJ Parekh, J Messer, J Fitzgerald, B Ercole, R Svatek The Journal of urology 189 (2), 474-479, 2013 | 327 | 2013 |
| Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladder E Xylinas, M Kent, L Kluth, A Pycha, E Comploj, RS Svatek, Y Lotan, ... British journal of cancer 109 (6), 1460-1466, 2013 | 289 | 2013 |
| ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, diagnosis, and molecular markers AM Kamat, PK Hegarty, JR Gee, PE Clark, RS Svatek, N Hegarty, ... European urology 63 (1), 4-15, 2013 | 283 | 2013 |
| Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort HM Fritsche, M Burger, RS Svatek, C Jeldres, PI Karakiewicz, G Novara, ... European urology 57 (2), 300-309, 2010 | 259 | 2010 |
| Effect of intravesical instillation of gemcitabine vs saline immediately following resection of suspected low-grade non–muscle-invasive bladder cancer on tumor recurrence: SWOG … EM Messing, CM Tangen, SP Lerner, DM Sahasrabudhe, TM Koppie, ... Jama 319 (18), 1880-1888, 2018 | 246 | 2018 |
| Discrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohort. RS Svatek, SF Shariat, G Novara, EC Skinner, Y Fradet, PJ Bastian, ... BJU international 107 (6), 2011 | 238 | 2011 |
| Alvimopan accelerates gastrointestinal recovery after radical cystectomy: a multicenter randomized placebo-controlled trial CT Lee, SS Chang, AM Kamat, G Amiel, TL Beard, A Fergany, RJ Karnes, ... European urology 66 (2), 265-272, 2014 | 235 | 2014 |
| Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients G Novara, RS Svatek, PI Karakiewicz, E Skinner, V Ficarra, Y Fradet, ... The Journal of urology 183 (6), 2165-2170, 2010 | 233 | 2010 |
| Intravesical rAd–IFNα/Syn3 for patients with high-grade, Bacillus Calmette-Guerin–refractory or relapsed non–muscle-invasive bladder cancer: a phase II randomized study ND Shore, SA Boorjian, DJ Canter, K Ogan, LI Karsh, TM Downs, ... Journal of Clinical Oncology 35 (30), 3410-3416, 2017 | 198 | 2017 |
| Cytokine panel for response to intravesical therapy (CyPRIT): nomogram of changes in urinary cytokine levels predicts patient response to Bacillus Calmette-Guérin AM Kamat, J Briggman, DL Urbauer, R Svatek, GMN González, ... European Urology 69 (2), 197-200, 2016 | 181 | 2016 |
| International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy SF Shariat, RS Svatek, D Tilki, E Skinner, PI Karakiewicz, U Capitanio, ... BJU international 105 (10), 1402-1412, 2010 | 174 | 2010 |
| Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumours JM Stern, R Svatek, S Park, M Hermann, Y Lotan, AI Sagalowsky, ... BJU international 100 (2), 287-290, 2007 | 168 | 2007 |
| The effectiveness of off-protocol adjuvant chemotherapy for patients with urothelial carcinoma of the urinary bladder RS Svatek, SF Shariat, RE Lasky, EC Skinner, G Novara, SP Lerner, ... Clinical Cancer Research 16 (17), 4461-4467, 2010 | 155 | 2010 |
| Microscopic haematuria at time of diagnosis is associated with lower disease stage in patients with newly diagnosed bladder cancer D Ramirez, A Gupta, D Canter, B Harrow, RW Dobbs, V Kucherov, ... BJU international 117 (5), 783-786, 2016 | 149 | 2016 |
| Age and body mass index are independent risk factors for the development of postoperative paralytic ileus after radical cystectomy RS Svatek, MB Fisher, MB Williams, SF Matin, AM Kamat, HB Grossman, ... Urology 76 (6), 1419-1424, 2010 | 148 | 2010 |
| Adaptive immune resistance to intravesical BCG in non–muscle invasive bladder cancer: Implications for prospective BCG-unresponsive trials M Kates, A Matoso, W Choi, AS Baras, MJ Daniels, K Lombardo, A Brant, ... Clinical cancer research 26 (4), 882-891, 2020 | 146 | 2020 |
